Effect of Panax notoginseng Saponins and Major Anti-Obesity Components on Weight Loss
The prevalence of individuals who are overweight or obese is rising rapidly globally. Currently, majority of drugs used to treat obesity are ineffective or are accompanied by obvious side effects; hence, the options are very limited. Therefore, it is necessary to find more effective and safer anti-o...
Main Authors: | Xuelian Zhang, Bin Zhang, Chenyang Zhang, Guibo Sun, Xiaobo Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.601751/full |
Similar Items
-
Targeting Orphan Nuclear Receptors NR4As for Energy Homeostasis and Diabetes
by: Chenyang Zhang, et al.
Published: (2020-11-01) -
Notoginsenoside R1 Protects Against Diabetic Cardiomyopathy Through Activating Estrogen Receptor α and Its Downstream Signaling
by: Bin Zhang, et al.
Published: (2018-11-01) -
Notoginsenoside R1 Protects db/db Mice against Diabetic Nephropathy via Upregulation of Nrf2-Mediated HO-1 Expression
by: Bin Zhang, et al.
Published: (2019-01-01) -
Peroxiredomin-4 ameliorates lipotoxicity-induced oxidative stress and apoptosis in diabetic cardiomyopathy
by: Bin Zhang, et al.
Published: (2021-09-01) -
An In Silico Model for Predicting Drug-Induced Hepatotoxicity
by: Shuaibing He, et al.
Published: (2019-04-01)